Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

Duncan R. McKenzie; Miguel Muñoz-Ruiz; Leticia Monin; Thanussuyah Alaguthurai; Thomas Lechmere; Sultan Abdul-Jawad; Carl Graham; Emily Pollock; Rosalind Graham; Kamila Sychowska; Jeffrey Seow; Catherine Tremain; Charalampos Gousis; Clara Domingo-Vila; Jack Cooper; Jennifer Vidler; Kasia Owczarczyk; Angela Swampillai; Hartmut Kristeleit; Michael H. Malim; Paul Fields; Piers E.M. Patten; Sophie Papa; Bernard V. North; Timothy Tree; Katie J. Doores; Adrian C. Hayday; Sheeba Irshad

doi:10.1016/j.ccell.2021.10.003

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

Duncan R. McKenzie, Miguel Muñoz-Ruiz, Leticia Monin, Thanussuyah Alaguthurai, Thomas Lechmere, Sultan Abdul-Jawad, Carl Graham, Emily Pollock, Rosalind Graham, Kamila Sychowska, Jeffrey Seow, Catherine Tremain, Charalampos Gousis, Clara Domingo-Vila, Jack Cooper, Jennifer Vidler, Kasia Owczarczyk, Angela Swampillai, Hartmut Kristeleit, Michael H. MalimPaul Fields, Piers E.M. Patten, Sophie Papa, Bernard V. North, Timothy Tree, Katie J. Doores, Adrian C. Hayday, Sheeba Irshad^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	1445-1447
Number of pages	3
Journal	CANCER CELL
Volume	39
Issue number	11
Early online date	12 Oct 2021
DOIs	https://doi.org/10.1016/j.ccell.2021.10.003
Publication status	Published - 8 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ccell.2021.10.003

Cite this

McKenzie, D. R., Muñoz-Ruiz, M., Monin, L., Alaguthurai, T., Lechmere, T., Abdul-Jawad, S., Graham, C., Pollock, E., Graham, R., Sychowska, K., Seow, J., Tremain, C., Gousis, C., Domingo-Vila, C., Cooper, J., Vidler, J., Owczarczyk, K., Swampillai, A., Kristeleit, H., ... Irshad, S. (2021). Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer. CANCER CELL, 39(11), 1445-1447. https://doi.org/10.1016/j.ccell.2021.10.003

@article{b1ae31d468ed456fbd89555ae9f1ae2e,

title = "Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer",

author = "McKenzie, {Duncan R.} and Miguel Mu{\~n}oz-Ruiz and Leticia Monin and Thanussuyah Alaguthurai and Thomas Lechmere and Sultan Abdul-Jawad and Carl Graham and Emily Pollock and Rosalind Graham and Kamila Sychowska and Jeffrey Seow and Catherine Tremain and Charalampos Gousis and Clara Domingo-Vila and Jack Cooper and Jennifer Vidler and Kasia Owczarczyk and Angela Swampillai and Hartmut Kristeleit and Malim, {Michael H.} and Paul Fields and Patten, {Piers E.M.} and Sophie Papa and North, {Bernard V.} and Timothy Tree and Doores, {Katie J.} and Hayday, {Adrian C.} and Sheeba Irshad",

note = "Funding Information: The authors declare no competing interests.",

year = "2021",

month = nov,

day = "8",

doi = "10.1016/j.ccell.2021.10.003",

language = "English",

volume = "39",

pages = "1445--1447",

journal = "CANCER CELL",

issn = "1535-6108",

publisher = "Cell Press",

number = "11",

}

McKenzie, DR, Muñoz-Ruiz, M, Monin, L, Alaguthurai, T, Lechmere, T, Abdul-Jawad, S, Graham, C , Pollock, E , Graham, R , Sychowska, K , Seow, J, Tremain, C, Gousis, C, Domingo-Vila, C, Cooper, J, Vidler, J, Owczarczyk, K, Swampillai, A, Kristeleit, H, Malim, MH , Fields, P , Patten, PEM , Papa, S , North, BV , Tree, T , Doores, KJ , Hayday, AC & Irshad, S 2021, 'Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer', CANCER CELL, vol. 39, no. 11, pp. 1445-1447. https://doi.org/10.1016/j.ccell.2021.10.003

TY - JOUR

T1 - Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

AU - McKenzie, Duncan R.

AU - Muñoz-Ruiz, Miguel

AU - Monin, Leticia

AU - Alaguthurai, Thanussuyah

AU - Lechmere, Thomas

AU - Abdul-Jawad, Sultan

AU - Graham, Carl

AU - Pollock, Emily

AU - Graham, Rosalind

AU - Sychowska, Kamila

AU - Seow, Jeffrey

AU - Tremain, Catherine

AU - Gousis, Charalampos

AU - Domingo-Vila, Clara

AU - Cooper, Jack

AU - Vidler, Jennifer

AU - Owczarczyk, Kasia

AU - Swampillai, Angela

AU - Kristeleit, Hartmut

AU - Malim, Michael H.

AU - Fields, Paul

AU - Patten, Piers E.M.

AU - Papa, Sophie

AU - North, Bernard V.

AU - Tree, Timothy

AU - Doores, Katie J.

AU - Hayday, Adrian C.

AU - Irshad, Sheeba

N1 - Funding Information: The authors declare no competing interests.

PY - 2021/11/8

Y1 - 2021/11/8

UR - http://www.scopus.com/inward/record.url?scp=85118492472&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2021.10.003

DO - 10.1016/j.ccell.2021.10.003

M3 - Letter

AN - SCOPUS:85118492472

SN - 1535-6108

VL - 39

SP - 1445

EP - 1447

JO - CANCER CELL

JF - CANCER CELL

IS - 11

ER -

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

UN SDGs

Access to Document

Other files and links

Cite this